title: Bleomycin, etoposide, and cisplatin for three cycles compared with etoposide and cisplatin for four cycles in good-risk germ cell tumors: is there a preferred regimen?
authors.forename: Lawrence H
authors.initials: LH
authors.lastname: Einhorn
authors.forename: Richard S
authors.initials: RS
authors.lastname: Foster
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D001761:Bleomycin / Q000008:administration & dosage; D002945:Cisplatin / Q000008:administration & dosage; D004334:Drug Administration Schedule; D005047:Etoposide / Q000008:administration & dosage; D006801:Humans; D008297:Male; D009373:Neoplasms, Germ Cell and Embryonal / Q000188:drug therapy*; D018570:Risk Assessment; D012307:Risk Factors
chemical_list: D001761:Bleomycin; D005047:Etoposide; D002945:Cisplatin